Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D
This study aims to benchmark and analyze the process development and manufacturing costs across the biopharmaceutical drug development cycle and their contribution to overall research and development (R&D) costs. This was achieved with a biopharmaceutical drug development lifecycle cost model th...
Saved in:
Main Authors: | Suzanne S. Farid (Author), Max Baron (Author), Christos Stamatis (Author), Wenhao Nie (Author), Jon Coffman (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Developments and opportunities in continuous biopharmaceutical manufacturing
by: Ohnmar Khanal, et al.
Published: (2021) -
An in-silico approach towards multivariate acceptable ranges in biopharmaceutical manufacturing
by: Marco Kunzelmann, et al.
Published: (2024) -
Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification
by: Virginie Philippe, et al.
Published: (2023) -
Design, Manufacturing, Characterization and Evaluation of Lipid Nanocapsules to Enhance the Biopharmaceutical Properties of Efavirenz
by: Grady K. Mukubwa, et al.
Published: (2022) -
In-line product quality monitoring during biopharmaceutical manufacturing using computational Raman spectroscopy
by: Jiarui Wang, et al.
Published: (2023)